ABSTRACT
INTRODUCTION

42
Acinetobacter species have emerged as one of high-priority hospital-acquired pathogens causing 43 substantial mortality and economic burdens (1). Among the Acinetobacter genomospecies A. pittii are also regarded as clinically relevant species with geographically dependent lower but 52 likely increasing incidence compared with A. baumannii (4-6). However, the genomospecies 53 within the Acb complex cannot be identified by routine biochemical methods (7-9).
54
Epidemiological and clinical studies of Acinetobacter spp. therefore often investigate the Acb 55 complex as a single entity, which is practical but limits the ability to differentiate the clinical 56 features of infection due to A. baumannii and non-baumannii Acb complex isolates (3).
57
Nonetheless, recent reports are starting to reveal the distinct clinical characteristics and outcomes 58 of patients infected with A. baumannii and non-baumannii Acb complex species, primarily A. 59 nosocomialis and A. pittii (5, 6, 10, 11) . included in the study. The infection status was identified from the hospital microbiology 88 database and confirmed to be hospital-acquired in nature using the diagnostic criteria of the colony forming units [CFUs] ). Those deemed to be colonized without infection were excluded.
93
For urinary tract infection, at least two clinical parameters had to be present (fever ≥ 38°C, Clinical features of patients infected with non-baumannii Acb complex and A. baumannii.
197
Comparison of the clinical features of patients infected with non-baumannii Acb complex (A. 198 nosocomialis or A. pittii) with those infected with CSAB and CRAB is shown in Table 2 .
199
Previous therapy with fluoroquinolones, cephalosporin and carbapenem was significantly less 200 frequent among the patients infected with non-baumannii Acb complex species than those 201 infected with CRAB but no difference was observed compared with those infected with CSAB.
In addition, the duration from admission to infection with non-baumannii Acb complex was 203 significantly shorter than those of CRAB while significantly longer than those of CSAB. We also 204 found that the proportion of patients who were exposed to invasive procedures among those 205 infected with non-baumannii Acb complex was higher than those infected with CSAB whereas it 206 was not different from those infected with CRAB. in vertebrate animal models.
298
In conclusion, the patients infected with non-baumannii Acb complex species had more baumannii (CSAB) and 2 carbapenem-resistant A. baumannii (CRAB) isolates and observed daily for 6 days. Survival rates were significantly higher for the larvae infected with non-baumannii Acb complex species than those infected with A. baumannii, either CSAB or CRAB (P < 0.05, Student's t-test), whereas there was no significant difference in survival between the larvae infected with CSAB and CRAB.
